CRC develops upon acquisition of a series of cancer driver mutations and genomic alterations in the tumor suppressor genes and protooncogenes, which are involved in multiple signaling pathways, such as Wnt, RAS-MAPK, TGF-β, and DNA mismatch-repair [2]. Here, TGFB1 is linked to cancer.